Replimune (REPL) Return on Assets (2018 - 2025)
Replimune's (REPL) quarterly Return on Assets came in at 0.01% in Q4 2025, little changed year-on-year from 0.01% in Q4 2024, and down 20.56% quarter-over-quarter from 0.01% in Q3 2025.
Replimune (REPL) Return on Assets (2018 - 2025) Analysis & Trends
Replimune has disclosed Return on Assets across 8 years of filings, most recently posting 0.01% for Q4 2025.
- Return on Assets for Q4 2025 came in at 0.01%, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.01% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
- Return on Assets came in at 0.01% for Q4 2025 at Replimune, down from 0.01% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.0% in Q1 2021 to a low of 0.01% in Q4 2025.
- The 5-year median for Return on Assets is 0.0% (2023), against an average of 0.0%.
- Peak annual rise in Return on Assets reached 0 bps in 2021, while the deepest fall reached 0 bps in 2021.
- Replimune's Return on Assets stood at 0.0% in 2021, then slipped by 29 bps to 0.0% in 2022, then tumbled by 36 bps to 0.0% in 2023, then retreated by 8 bps to 0.0% in 2024, then sank by 110 bps to 0.01% in 2025.
- The last three Return on Assets figures came in at 0.01% (Q4 2025), 0.01% (Q3 2025), and 0.01% (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | -0.80% |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -0.01% |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 0.00% |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -0.01% |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 0.00% |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 0.00% |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -0.01% |
| 10 | Replimune | 780.01 Mn | 510.88 Mn | - | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | -0.01% |
| Jun 30, 2025 | -0.01% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |
| Mar 31, 2021 | 0.00% |